TCONTRACON Pharmaceuticals Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMay 14
Mkt Cap$109,725.00
Vol23,886.00

About

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of TRACON Pharmaceuticals Inc?
What is the 52-week high for TRACON Pharmaceuticals Inc?
What is the 52-week low for TRACON Pharmaceuticals Inc?
What is TRACON Pharmaceuticals Inc stock price today?
What was TRACON Pharmaceuticals Inc stock price yesterday?
What is the 50-day moving average of TRACON Pharmaceuticals Inc?

Latest TCON News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.